All Publications


  • Transcriptomic convergence and the female protective effect in autism NATURE Andersen, R. E., Talukdar, M., Sakamoto, T., Exposito-Alonso, D., Song, J. H. T., Qian, X., Lee, S., Murugan, N., Delgado, R. N., Zhao, S., Eichfeld, G., Harms, J., Page, D. C., Walsh, C. A. 2026

    Abstract

    Autism spectrum disorder (ASD) is highly heritable, and mutations in hundreds of genes have been implicated as individually rare causes of ASD1-3. Understanding how disruptions to these functionally diverse genes lead to the core features of ASD remains a major challenge4. Moreover, ASD is three- to four-fold more common in male than in female individuals5, and female autistic people tend to carry more autosomal risk alleles for ASD compared with their male counterparts6,7; however, the biological basis of this 'female protective effect' (FPE) has remained unknown8,9. Here we show that individual perturbations of 18 ASD genes in human neural progenitor cells converge on shared effects on gene expression, including widespread downregulation of other ASD genes. De novo reconstruction of a gene regulatory network enabled identification of central transcriptional regulators that drive this transcriptomic convergence, including prominent ASD gene CHD8 and candidates including REST. Furthermore, X-linked transcription factor ZFX, which is expressed from both the active and the inactive X chromosomes in female individuals10, emerged as a key activator of many ASD genes: we propose that the higher ZFX expression level observed in the female brain can buffer damaging mutations in diverse ASD genes, contributing to the female protective effect. Together, these results show how key gene regulatory networks can become broadly and similarly dysregulated upon disruption of individual ASD genes and provide molecular insight into the female protective effect in ASD.

    View details for DOI 10.1038/s41586-026-11236-6

    View details for Web of Science ID 001923706200001

    View details for PubMedID 42983080

    View details for PubMedCentralID 10726699

  • Activation of neurogenesis improves amyloid-β pathology and cognitive function through AMP kinase signaling in Alzheimer's disease model mice CELL REPORTS Fukui, M., Kaise, T., Masaki, T., Sakamoto, T., Kageyama, R. 2026; 45 (4): 117250

    Abstract

    Adult hippocampal neurogenesis declines with aging and in neurological disorders, leading to cognitive impairment. We previously showed that inducing Plagl2 and antagonizing Dyrk1a (iPaD) rejuvenates aged neural stem cells (NSCs), enhancing neurogenesis and cognition in aged mice. Here, we found that NSC-specific iPaD treatment activates neurogenesis, reduces amyloid-β deposition, and improves cognition in Alzheimer's disease model mice. Transcriptomic analysis revealed widespread changes in gene expression in the hippocampus after iPaD treatment. The upregulated genes include those associated with astrocyte and microglial activation involved in amyloid-β clearance, while several genes upregulated in Alzheimer's disease are downregulated. Among the latter genes, knockdown of Prkag2 in the hippocampus most effectively enhances neurogenesis and reduces amyloid-β accumulation. Notably, both iPaD treatment and Prkag2 knockdown activate AMP-activated protein kinase signaling, upregulating genes involved in autophagy and cellular homeostasis. These results suggest that Prkag2 may represent a promising therapeutic target for neurodegenerative diseases, including Alzheimer's disease.

    View details for DOI 10.1016/j.celrep.2026.117250

    View details for Web of Science ID 001742653400001

    View details for PubMedID 41964958

  • In vivo transplantation of mammalian vascular organoids onto the chick chorioallantoic membrane reveals the formation of a hierarchical vascular network. Scientific reports Kowalski, W. J., Vatti, S., Sakamoto, T., Li, W., Odutola, S. R., Liu, C., Chen, G., Boehm, M., Mukouyama, Y. S. 2025; 15 (1): 7150

    Abstract

    The dynamic remodeling of the nascent vascular network into a mature hierarchy is essential for embryo survival. Cell behaviors and signaling mechanisms are often investigated with animal models and perfused microchannels, giving insights into this process. To support these studies and enrich our understanding, we demonstrate a complementary approach using vascular organoids. Organoids initially form a primitive endothelial plexus lined with NG2+/PDGFRβ+ mural cell progenitors containing immature pericytes, but there is no formation of large-diameter vessels covered with αSMA+ cells containing immature vascular smooth muscle cells (vSMCs). After transplantation to the chick chorioallantoic membrane, the network reorganizes into a branched architecture with large-diameter vessels covered by αSMA+ cells. We additionally show that blood flow from the host circulation perfuses the organoid. Compared with the developing skin vasculature in mouse embryos, organoids successfully recapitulate vascular morphogenesis, both in vitro and after transplantation. The model described here presents a further approach to enhance the study of vascular remodeling.

    View details for DOI 10.1038/s41598-025-91826-y

    View details for PubMedID 40021912

    View details for PubMedCentralID PMC11871353

  • Chromosomal structural rearrangements implicate long non-coding RNAs in rare germline disorders. Human genetics Andersen, R. E., Alkuraya, I. F., Ajeesh, A., Sakamoto, T., Mena, E. L., Amr, S. S., Romi, H., Kenna, M. A., Robson, C. D., Wilch, E. S., Nalbandian, K., Piña-Aguilar, R., Walsh, C. A., Morton, C. C. 2024; 143 (7): 921-938

    Abstract

    In recent years, there has been increased focus on exploring the role the non-protein-coding genome plays in Mendelian disorders. One class of particular interest is long non-coding RNAs (lncRNAs), which has recently been implicated in the regulation of diverse molecular processes. However, because lncRNAs do not encode protein, there is uncertainty regarding what constitutes a pathogenic lncRNA variant, and thus annotating such elements is challenging. The Developmental Genome Anatomy Project (DGAP) and similar projects recruit individuals with apparently balanced chromosomal abnormalities (BCAs) that disrupt or dysregulate genes in order to annotate the human genome. We hypothesized that rearrangements disrupting lncRNAs could be the underlying genetic etiology for the phenotypes of a subset of these individuals. Thus, we assessed 279 cases with BCAs and selected 191 cases with simple BCAs (breakpoints at only two genomic locations) for further analysis of lncRNA disruptions. From these, we identified 66 cases in which the chromosomal rearrangements directly disrupt lncRNAs. In 30 cases, no genes of any other class aside from lncRNAs are directly disrupted, consistent with the hypothesis that lncRNA disruptions could underly the phenotypes of these individuals. Strikingly, the lncRNAs MEF2C-AS1 and ENSG00000257522 are each disrupted in two unrelated cases. Furthermore, we experimentally tested the lncRNAs TBX2-AS1 and MEF2C-AS1 and found that knockdown of these lncRNAs resulted in decreased expression of the neighboring transcription factors TBX2 and MEF2C, respectively. To showcase the power of this genomic approach for annotating lncRNAs, here we focus on clinical reports and genetic analysis of seven individuals with likely developmental etiologies due to lncRNA disruptions.

    View details for DOI 10.1007/s00439-024-02693-y

    View details for PubMedID 39060644

    View details for PubMedCentralID PMC11294402